Tumors with dominant PCSK9 mutations included cervical adenocarcinoma, esophageal squamous cell carcinoma, esophagogastric adenocarcinoma, renal non-clear cell carcinoma, COAD, HNSC, KIRC, PAAD. This evidence concerns the gene PCSK9 and gastroesophageal junction adenocarcinoma.